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Abstract 
Psoriasis is chronic disorder which is commonly encountered in day to day’s clinical practices.  It is a 
relapsing & remitting disease of skin causing social isolation, cosmetic & psychological embarrassment as well as 
difficulties in leading social life. Even though it can be considered as an autoimmune disorder affecting skin, it 
cannot always be treated as somatic lesion, it is infact multifactorial in origin & conditioned by various 
constitutional & environmental factors. Due to altered life style, lack of physical exercise, unhygienic, mental 
stress & over eating skin diseases are commonly observed. Although Eka-kushta is a rakta pradoshaja, vata-kaha 
pradhana tridoshaja kshudra kushta, it bears a great resemblance with psoriasis. The current treatment modalities 
have their own limitations & the drugs have considerable side effects when used for a longer period. 
Therefore, there is a need for more comprehensive, economical & safe medications and methods of 
management of psoriasis. Hence a clinical study was conducted on 20 patients assigned to evaluate the Efficacy of 
Kutaja Siddha Haritaki Churna and Vyadhignadi taila after virechana karma in the Management of Ekakushta vis-
a-vis Chronic Plaque Psoriasis. At the end of  30 days of treatment involving shodhana (virechana) followed by 
shamanoushadhis  and external medication resulted in significant improvement in the overall effect of therapy in 
reducing itching scaling, erythema and thickness .So it can be inferred that ayurvedic management of chronic 
plaque psoriasis with above mentioned medicines can be effectively used. 
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Introduction 
In Ayurvedic science almost all the skin diseases 
are explained under kushta rogadhikara and are 
classified under seven Mahakushta and eleven kshudra 
kushta. All types of kushta are considered as 
raktapradoshaja vikara.(1) Ekakushta is one among 
eleven varieties of kshudra kushta. Further ekakushta is 
stated to be tridoshaja with the predominance of 
kaphavata doshas.(2) It is characterised by 
Aswedanam, Mahavastu, Matsyashakalavat twacha .(3) 
which bears a greater resemblance with Chronic plaque 
psoriasis. Psoriasis is a chronic autoimmune disease, 
which appears as red, scaly patches on the skin (4) 
known as chronic psoriatic plaques.  These plaques 
give it a silvery-white appearance. Plaques are 
commonly seen on elbows and knees, but can affect 
any area including the scalp, palms, soles and genitals 
(5). The world wide prevalence of psoriasis is around 
2% but studies in developed countries have reported 
higher prevalence rates of an average about 4.6%, 
Nearly 2/3rd of people with psoriasis have a mild form 
of the disease, with less than 3 % of the skin surface of 
the body affected, but others have more extensive 
involvement of the skin(6). Plaque psoriasis occurs 
worldwide,  although its prevalence varies with race, 
geography and environmental factors(7).Inspite of 
various treatment modalities adopted in the 
contemporary medicine, owing to its recurrent nature 
Chronic plaque psoriasis still remains a challenge to 
treat. Ayurveda explains the treatment of ekakushta with 
the dual therapies shodhana and shamana. 
Bahirparimarjana chikitsa has also been explained for 
the treatment of twakgata vikaras (8) Various studies 
conducted in different centers has proven the efficacy of 
vamana and virechana in the management of ekakushta. 
Even though vamana and virechana (shodhana) 
effectively combats the chronic plaque psoriasis, nature 
of the disease is such that there is a high chance of re-
occurance. Hence the disease needs to be managed with 
shamana aushadis after shodhana. So to disintegrate 
the samprapti and to increase the duration between 
relapse, a formulation which has not only kushtaghna 
effect but also works at the level of dhatwagni 
countering kapha and vata dosha is desirable. Hence the 
current study is taken up to assess and compare the 
clinical efficacy of kutaja siddha haritaki choorna and 
vyadhignadi taila with darvyadi kwatha and chitrakadi 
taila, after samsarjana krama of virechana in the 
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management of Ekakushta vis-à-vis chronic plaque 
psoriasis.In the present study 20 cases of Eka-kushta vis-
à-vis Chronic plaque psoriasis were sampled in a single 
group. 
 
Objectives of study 
To evaluate the efficacy of kutaja siddha haritaki 
choorna and vyadhignadi taila  after virechana in 
ekakushta  vis-à-vis chronic Plaque psoriasis. 
 
Materials and Methods 
Materials 
The Materials used in the study were : 
 Kutajasiddha Haritaki Choorna - Kutaja twak, 
Chitraka (root), Nimba-twak, Araghwadha 
(twak), Khadira (twak), Sapta Parna and 
Haritaki (phala)[9]. 
 Vyadhignadi Taila- Kushta (root), Asana(twak), 
Tuvaraka (beeja), Khadira (twak) and Arushkara 
( phala majja)[10]. 
 
Source of  Drugs and Method of preparation 
 Kutajasiddha Haritaki Choorna, Vyadhignadi 
Taila were specifically prepared for the purpose 
of study and procured from SN Pandit & Sons 
Pharmacy (GMP certified Unit), Shankar matt 
main road, Opposite to Nataraja choultry, 
Mysuru. 
 
Methods –Source of the data 
Subjects were selected from the OPD and IPD of 
Government Ayurveda Medical College & Hospital, 
Mysuru and Government Hi-Tech Panchakarma 
Hospital, Mysuru. 
 
Sample size 
     The study was completed on 20 subjects of 
Eka-kushta vis-à-vis Chronic Plaque Psoriasis 
irrespective of gender, socio-economic status and 
religion, fulfilling the inclusion criteria were registered 
for the study.The selected subject’s detailed profile was 
prepared as per the  proforma designed for the study.  
 
Sampling method 
Incidental selection and Purposive sampling 
technique was employed. S 
 
Study design 
It was an observational clinical study with pre-
post test design. 
 
Inclusion Criteria 
 Subjects with the lakshana of  Ekakusta co-
relating with the signs and symptoms of Chronic 
plaque psoriasis were included 
 Subjects between the age group of 18 to 60 years 
irrespective of gender were included.  
 Subjects of Eka-kushta ,who were fit for 
virechana karma were only included. 
 Both fresh cases and subjects who has undergone 
treatment earlier also were included.  
 
Exclusion Criteria: 
 Subjects with uncontrolled DM, uncontrolled 
HTN, Ischemic Heart Disease, Immuno 
compromised patients were excluded. 
 Subjects suffering from any other systemic 
disorders which may interfere with the 
intervention were excluded.  
 Pregnant and lactating women were excluded.  
 Chronic plaque psoriasis with severe infective 
lesion were excluded.  
 
Diagnostic criteria 
Diagnosis was made based on the lakshana of 
ekakushta and signs and symptoms of Chronic plaque 
psoriasis. Positive Auspitz sign. Positive candle grease 
sign, Positive koebner  phenomenon 
 
Assessment Criteria 
To assess the effect of the therapy, the Psoriasis 
Area and Severity Index (P.A.S.I) scoring method was 
adopted. 
 
Area 
For each skin section, the amount of skin 
involved was measured as percentage of the skin of 
affected part of the body and then a score from 0-6 was 
assigned as follows: 
 
Table-1: Showing Diseased Skin Grading 
 
 
The severity was measured in four different 
Parameters - Itching ,Erythema ,Scaling , Thickness 
Again all these were measured separately for 
each skin section. These were measured on a scale of 0 - 
4, from none to maximum according to the following 
chart- 
 
Table-2: Showing Severity Score 
 
 
After figuring out all the scores, final “PASI” 
was calculated. Thus PASI scoring was calculated 
Coverage Score 
0 0 
<10% 1 
10-29% 2 
30-49% 3 
50-69% 4 
70-89% 5 
90-100% 6 
Severity Score 
None 0 
Mild 1 
Moderate 2 
Severe 3 
Very Severe 4 
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before starting the treatment, after samsarjana krama 
and after the completion of the Intervention and overall 
percentage in “P.A.S.I” scoring was calculated to assess 
the effect of the Intervention. 
 
Overall Assessment of Clinical Response 
 Complete Remission – 100% reduction in PASI 
score  
 Marked improvement –75 - 99% reduction in 
PASI score 
 Moderate improvement –50%-74% reduction in 
PASI score 
 Mild improvement –25 -49% reduction in PASI 
score 
  
Assessment schedule 
 1st assessment was done, when Subjects reported 
i.e. before the  treatment. 
 2nd assessment (Pre test) was done before 
administering the intervention i.e. after the 
samsarjana krama of virechana karma (0 day)  
 3rd assessment (Post test) assessment was done 
after completion of the intervention. i.e. on 20th 
day.  
 
Intervention 
Before administering the intervention, all 20 
subject were administered virechana karma with trivrit 
lehya and dose was fixed depending upon koshta of the 
patients, Samsarjana krama was carried out depending 
upon the koshta shuddhi. From the next day of  
Samsarjana karma, Kutaja siddha haritaki  choorna 12 
gms in three equally divided doses, thrice  daily with 
madhu as anupana after food and Vyadhignadi taila for 
external application twice daily, was given for 
continuous 20 days  
 
Statistical methods 
 The results were compared and analysed by using 
following statistical methods.  
 Descriptive statistics 
 Chi-square test. 
 
Observations and Results  
In the present study among 20 subjects who 
completed the clinical trial, a maximum of  7 subjects 
belonged to the age group of 51 –60 years, 5 belonged 
to the age group of 31-40 years, 4 belonged to the age 
group less than 30 years and 4 belonged to age group of 
41-50 years. Among the 20 subjects, 11 were male and 
9 were female. The observation regarding the socio 
economic status of the individual subjects in this study, 
showed that 9 of them belonged to Lower middle class, 
8 belonged to below poverty line , 3 belonged to upper 
middle class. The observation regarding the food habits 
of the subjects in this study showed that majority of 
them i.e.16 belonged to Mixed food habits (veg & non-
veg) and 4 belonged to vegetarian food pattern. In the 
Present study, it was observed that maximum subjects 
i.e. 14 were from Rural locality and 6 belonged to 
Urban locality. And observation based on family history 
of Eka Kushta vis-a-vis Chronic Plaque Psoriasis, was 
present in  only one subject and absent in 19 subjects. 
The observation regarding the mode of onset of Eka 
Kushta in subjects in this study showed that all 20 
subjects had gradual onset. In this study, 7 subjects  
approached the hospital for the first time to take 
treatment and 13 had already taken different forms of 
treatment of varying duration. Among 20 subjects, 3 
had chronicity of less than year, 12 with chronicity of 1-
5 years, 5 with chronicity of 6-10 years. Among 20 
subjects, 2 presented with site of onset on Scalp, 3on 
Elbows, 0 on abdomen, 1 on Knee, 4 patient on back, 0 
on palm and 10 on leg. Among 20 subjects, all 20 
reported with worsening of symptoms in winter season. 
Discussion and results 
Total PASI of Head Region 
In single Group for all 20 subjects  mean was 2.5350 with SD of 6.26656 before treatment , 0.9100 with SD of  
2.10711 after samsarjana krama (pre test) and 0.0600 with SD of 0.22572 after Intervention (post test). Thus the 
result of Total PASI of Head Region is statistically highly significant. 
 
Table no-03 Showing Total PASI of Head region 
 
 
 
Total PASI of Upper Extremities : For  all 20 subjects mean was 6.9700 with SD of 5.15824 before treatment, 
3.0500 with SD of 3.06826 after samsarjana karma (pre test) and 0.7100 with SD of 1.10401 after Intervention (post 
test). Thus the result of Total PASI of Upper Extremities is statistically highly significant for all 20 subjects. 
 
 
 Mean Std. Deviation N 
PASI_head_BT 2.5350 6.26656 20 
PASI_head_AS 0.9100 2.10711 20 
PASI head_AT 0.0600 0.22572 20 
Source Type III Sum of Squares Df Mean Square F Sig. 
Change 64.249 2 32.124 6.027 0.004 
Change * Grp 10.450 2 5.225 0.980 0.380 
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Table no-04 Showing Total PASI of Upper Extremities  
 
 
 
Total PASI of Trunk 
The mean was 10.9450 with SD of 6.73197 Before Treatment, 4.5850 with SD of 3.33818 After samasarjana 
krama (pre test) and 0.7600 with SD of 1.23731 After Intervention (post test) for all 20 subjects. Thus the result of 
Total PASI of Trunk  is statistically highly significant.  
 
Table No-05 Showing Total PASI of Trunk  
 
 
 
Total PASI of Lower Extremities 
The mean was 17.9500 with SD of 14.02102 Before Treatment, 8.4100 with SD of 7.91653 After Samsarjana 
Krama (pre test) and 1.2900 with SD of 2.18365 After Intervention(post test) for all 20 subjects. Thus the result of 
Total PASI of lower Extremities is statistically highly significant. 
 
Table No-06 Showing Total PASI of Lower Extremities  
 
 
 
The overall result of the study revealed that all 20 subjects has Statistically significant results i.e. out of 20 
subjects 3(15%) got complete relief, 10(50%) got marked relief and 7(35%) had moderate relief . The effect of 
intervention on Itching, Erythema, Scaling, Thickness, Area was statistically significant in all the areas for all 20 
subjects.  
By this we can infer that, shamanoushadhis i.e. Kutaja siddha haritaki choorna and Vyadhignadi taila has 
good result in the management of ekakushta vis-à-vis chronic plaque psoriasis. 
 
 
 Mean Std. Deviation N 
PASI_ue_BT 6.9700 5.15824 20 
PASI_ue_AS 3.0500 3.06826 20 
PASI ue_AT .7100 1.10401 20 
Source Type III Sum of Squares Df Mean Square F Sig. 
Change 965.453 2 482.726 81.904 0.000 
Change * Grp 7.821 2 3.910 0.663 0.518 
 Mean Std. Deviation N 
PASI_trunk_BT 10.9450 6.73197 20 
PASI_trunk_AS 4.5850 3.33818 20 
PASI_trunk_AT .7600 1.23731 20 
Source Type III Sum of Squares Df Mean Square F Sig. 
Change 1304.142 2 652.071 54.561 0.000 
Change * Grp 98.088 2 49.044 4.104 0.020 
 Mean Std. Deviation N 
PASI_le_BT 17.9500 14.02102 20 
PASI_le_AS 8.4100 7.91653 20 
PASI_le_AT 1.2900 2.18365 20 
Source Type III Sum of Squares Df Mean Square F Sig. 
Change 5778.771 2 2889.385 91.010 0.000 
Change * Grp 4.803 2 2.401 0.076 0.927 
Table No-07 Showing Overall Assessment of PASI in Percentage  
Overall  
Complete (100%) 3 15.0% 
Marked (75-99%) 10 50.0% 
Moderate (50-74%) 7 35.0% 
Total Total 20 100.0% 
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Graph No-01 - Showing overall assessment of PASI in percentage  
  
Fig 1: Before treatment  
 
Fig 2: After treatment  
 
Probable mode of action of Kutaja Siddha Haritaki 
Choorna 
Action on Dosha 
Kutajasiddha haritaki choorna acts as 
tridoshahara 
By the effect of  tikta and kashaya rasa of all the 
drugs, the pitta dosha is pacified and due to the ushna 
veerya vata kapha dosha is pacified, it acts as 
kanduhara raktashodhaka by acting on reduction of 
vitiated kaphadosha 
It is kushtaghna by the  effect  (prabhava) of 
drugs like Khadira, Kutaja,Saptaparna and Aragwadha. 
 
Action on Dhatu 
Kutaja siddha haritaki choorna has tikta and 
kashaya rasa, these two rasa by the virtue of their 
pharmacological properties causes Tvak, mamsa 
sthirikarana (nourishment and strengthening of skin and 
muscle) It also does Vishaghnata (removes toxins), 
Kledaupashosana  and ropana (induces the healing 
process). 
By the Samsrana karma of  Araghwadha there 
will be shodhana of vitiated dosha. 
     Pharmacological researches on few drugs like 
Haritaki, Nimba and Saptaparna have     shown that 
these ingredients acts at the skin level and helps the skin 
to become healthy. Viz; Haritaki exhibited potent 
improvement of erythema and scaling scores, decrease 
of epidermal, ear and skin-fold thickening, decrease of 
tumor necrosis factor α (TNFα), interleukin (IL)-17A, 
IL-23 and matrix metalloproteinase (MMP)-9 
expression and decrease of keratinocyte proliferation.
[11] 
Nimba shows therapeutic role in enhancement of 
antioxidant activity, inhibition of bacterial growth, and 
modulation of genetic pathways. Nimba plays role as 
free radical scavenging properties due to rich source of 
antioxidant. Nimba also plays role as anti-inflammatory 
via regulation of pro inflammatory enzyme activities 
including cyclo oxygenase (COX), and lipoxygenase 
(LOX) enzyme.[12] 
Saptaparna (Alstonia scholaris)-inhibits all 
inflammatory activity in human keratinocyte cell, it 
decreases skin irritation and increasing the anti-aging 
function.[13] 
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Probable mode of action of Vyadhignadi Taila 
Action on Dosha 
Vyadhignadi taila pacifies kapha due to its katu 
rasa, laghu, ruksha and teekshna guna, as it possess 
ushna veerya it pacifies both vata and kapha. Pitta 
shamana takes place due to tikta and kashaya rasa. 
 
Action on Dhatu 
The dravyas with Tikta rasa causes 
shtireekarana of mamsa and twacha, also does twak 
prasadana and rakta vishodhana and so becomes 
twachya and varnya. Its deepana property enhances the 
agni at twacha level by acting on bhrajaka pitta and 
may help in reducing the Krishna aruna varna of  
twacha. 
Kushthagna property of drugs like Asana[14] 
Bhallataka[15], Tuvaraka[16] directly helps in vyadhi 
pratyanika chikitsa. Asana is established to have 
pharmacological activity as it inhibits T-cell 
proliferation[17]. Bhallataka has immuno modulatory 
effect and anti-inflammatory effect. S.anacardium  has 
alfatoxin B1 and mono hydroxy phenols  which has 
effective dermatological response[18] 
Krimighna property of the drug may prevent 
secondary infection as well as help in reducing the 
lesions. 
Kushta (S.lappa) decreases immunoglobulin E, 
cytokines and chemokines with reduction in 
histopathological features of psoriasis[19]. 
Thus combined effect of all the drugs of 
vyadhighnadi taila contributed in normalising the skin. 
The taila also acts by keratinocyte proliferation 
inhibition, retarding the cell division to 90% level. 
 
Conclusion 
On the basis of the conceptual analysis and 
observations made in the present study, the following 
conclusions were drawn. 
Eka-kushta is a vata kaphaja rakta pradoshaka 
vyadhi and one among the kshudra kushta and it bears a 
greater resemblance with chronic plaque psoriasis. 
Symptoms like Matsyashakalopamam, Krishna 
aruna mandala, mahavastu and Abhrakapatra sadrusha 
lesions are the cardinal features of eka-kushta and they are 
similar to that of plaque psoriasis. 
An observational clinical study was conducted on 
20 subjects, who was assigned in a single Group were 
treated with Kutaja siddha haritaki choorna  internally and 
Vydhignadi taila for external application, for consecutive 
20 days. Intervention was started after samsarjana krama 
of  virechana . 
In single Group with 20 subjects  PASI score was 
reduced remarkably and showed clinically significant 
result in reduction of all the symptoms. The Overall 
assessment showed complete relief in 3 subjects, 10 
subjects got marked relief and 7 subjects got moderate 
relief.  
Hence this study showed that kutajasiddha haritaki 
choorna and vyadhignadi taila has good result in the 
management of Eka-kushta vis –a –vis Chronic plaque 
psoriasis. 
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